Chongchang Zhou

21PUBLICATIONS
14CO-AUTHORS
Haematological tumoursInnate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 19, 2025
HMMR in human cancers: regulatory mechanism and biological function.

Yanghao Hu, Yifei Zhang, Jiali He

|Sep 15, 2025
Development and validation of an immune-related gene signature for the prognostic and immune landscape prediction in head and neck squamous cell carcinoma by integrated analysis of machine learning and Mendelian randomization.

Zhengyu Wei, Guoli Wang, Yanghao Hu

|Dec 22, 2022
High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.

Shuang Ye, Dan Wang, Ming Jin

|Sep 09, 2022
Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma.

Juntao Huang, Ziqian Xu, Zhechen Yuan

|Jul 23, 2022
Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.

Yiming Shen, Zhengyu Wei, Chongchang Zhou

|Jun 17, 2022
<i>CD3D</i>: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma.

Zhengyu Wei, Yiming Shen, Chongchang Zhou

Pageof 4

Frequent Collaborators

9 joint publications

Zhisen Shen

5 joint publications

Dong Ye

4 joint publications

Juntao Huang

4 joint publications

Hongxia Deng